Study objective Clinical repercussions of perioperative treatment with ACEIs/ARBs. Design
Systematic review according to PRISMA statement. Setting Perioperative period. Patients 29 …

BACKGROUND: The global rate of major noncardiac surgical procedures is increasing
annually, and of those patients presenting for surgery, increasing numbers are taking either …

Objective The aim of this study was to find out whether the preoperative continuation of
angiotensin-converting enzyme inhibitor (ACE-I) or angiotensin II receptor blocker (ARB) …

Background Patients who use angiotensin-converting enzyme inhibitors
(ACEIs)/angiotensin II receptor blockers (ARBs) are prone to developing side effects like …

Aims: This study is aimed to determine the effect of preoperative discontinuation of
angiotensin-converting enzyme inhibitors (ACEI) or angiotensin II receptor antagonists …

First, clinicians should consider key components and implications of the statistical meta-
analysis itself. While this unique tool can lend powerful insights to summarizing disparate …

Since the introduction of ACEIs and ARBs into clinical practice, their use during the
perioperative period has been controversial. Although these medications increase the risk of …

BACKGROUND: The continued use of angiotensin-converting enzyme inhibitors (ACEIs)
and angiotensin II subtype I receptor antagonists (ARBs) medications in the preoperative …

JUSTIFICATIVA E OBJETIVOS: Tem sido sugerida a suspensão de medicamentos como os
inibidores da enzima conversora de angiotensina (IECA) com base em relatos de …

Angiotensin II antagonists (AIIA) are part of a new rational treatment of hypertension.
Because adverse circulatory effects during anesthesia can occur in patients chronically …